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Constraint-based modeling of metabolism - interpreting predictions of growth and ATP synthesis in 
human and yeast 
Avlant Nilsson 
Department of Biology and Biological Engineering 
Chalmers University of Technology 
 
Abstract 
Growth is the primary objective of the cell. Diseases arise when cells diverge from a healthy 
growth-pattern. An increased understanding of cellular growth may thus be translated into 
improved human health. The cell requires materials and free energy (in the form of ATP) in order 
to grow, metabolism supplies the cell with this. The rate of metabolism is ultimately constrained 
by the biophysical properties of the metabolic enzymes. Interactions between the constraints and 
the growth-objective gives rise to metabolic trade-offs, e.g. between ATP synthesis from 
respiration and fermentation. We can gain quantitative insight into these processes by simulating 
metabolism using mathematical models. In this thesis I simulated the metabolism of four biological 
systems: the infant, cancer, yeast and muscle. The simulations demonstrated how a shift in 
metabolic strategy may increase the rates of ATP synthesis and growth. These increased metabolic 
rates come at the expense of decreased resource efficiency, i.e. ATP produced per carbon 
consumed. The effect was primarily caused by the low catalytic efficiency of the respiratory enzyme 
complexes I and V. By shifting from respiratory to fermentative ATP synthesis, the cell was able 
to bypass these constraints. An intermediate strategy involved bypassing only complex I. The 
phenomenon was experimentally corroborated in the working muscle, and it is the native state of 
the yeast Saccharomyces cerevisiae (which lacks complex I). The differences in efficiency between the 
different metabolic pathways also explained why cells grow faster on some carbon sources, e.g. the 
specific growth rate for yeast is higher on glucose than on ethanol. These models were extended 
to predict the world-record running-speeds at different distances, by taking the sizes of the body’s 
nutrient-deposits into account. A metabolic strategy employed by cancer cells involved excretion 
of the amino acid glutamate. The simulations showed a mechanistic relation to catabolism of 
branched-chain amino acids and the localization of amino acid metabolism to different cellular 
compartments. By experimentally inhibiting glutamate excretion using an off-the-shelf drug 
(sulfasalazine), the growth rate of a cancer cell line was reduced. The metabolic modeling involved 
integration of various types of data and thus demonstrated the potential to unify knowledge from 
different studies and domains. This exposed contradictory claims in literature and highlighted 
knowledge-gaps that need to be filled to further improve human health. 
 
Keywords: enzyme-constraints, flux balance analysis, tumor, the Warburg effect, the Crabtree effect, 
lactate threshold, metabolite depletion, stunting, cellular economy, uncoupling. 
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Vilkorsbaserad modellering av metabolismen – tolkning av prediktioner om tillväxt och ATP-syntes i 
människa och jäst 
Avlant Nilsson 
Institutionen för Biologi och bioteknik 
Chalmers tekniska högskola 
 
Sammanfattning 
Cellens primära målsättning är att växa. Celler som avviker från ett hälsosamt tillväxtmönster kan 
ofta orsaka sjukdomar. Ökad kunskap om celltillväxt kan därmed omsättas i förbättrad hälsa. För 
att växa behöver cellen material och energi (i form av ATP), metabolismen förser cellen med detta. 
Takten på metabolismen bestäms i sista hand av de biofysiska egenskaperna hos dess enzymer. I 
interaktionen mellan de biofysiska villkoren och cellens tillväxtmål uppstår avvägningar mellan 
olika strategier för metabolismen, t.ex. mellan ATP syntes genom respiration eller fermentering. 
En kvantitativ inblick i dessa processer kan uppnås genom att simulera metabolismen med hjälp 
av matematiska modeller. I denna avhandling simulerade jag metabolismen hos fyra biologiska 
system: spädbarn, cancer, jäst och muskel. Simuleringarna visade hur ett byte av strategi kunde öka 
takten på ATP-syntesen och tillväxten. Ökningen kom dock på bekostnad av minskad 
resurseffektivitet, d.v.s. mängden ATP som producerades per förbrukat kol. Detta berodde främst 
på låg katalytisk effektivitet hos de respiratoriska enzymkomplexen I och V. Genom att byta 
strategi i ATP syntesen från respiration till fermentering så kunde cellen kringgå komplexen. En 
mellanliggande strategi innefattade att endast förbikoppla komplex I. Det fenomenet bekräftades 
experimentellt i en arbetande muskel, och det utgör normaltillståndet för jästen Saccharomyces 
cerevisiae (som helt saknar komplex I). Effektivitetsskillnader mellan de olika vägarna i 
metabolismen förklarade också varför celler växer fortare på vissa kolkällor än andra, t.ex. så växer 
jäst fortare på glukos än på alkohol. Modellerna utvidgades så att de kunde förklara skillnaderna i 
världsrekordhastighet i löpning på olika distanser, genom att ta hänsyn storleken på reserverna av 
olika näringsämnen. En strategi som används av cancerceller involverade utsöndring av 
aminosyran glutamat. Simuleringarna visade en mekanistisk relation med nedbrytningen av 
grenade aminosyror och med lokalisering av aminosyrametabolismen till olika delar av cellen. 
Genom att inhibera glutamatutsöndringen experimentellt med hjälp av ett läkemedel (sulfasalazin), 
kunde tillväxttakten reduceras i en cancercellinje. Olika typer av data integrerades med hjälp av 
modellen och påvisade därigenom dess potential i att förena kunskaper från olika studier och 
domäner. Modellerna exponerade motsägelsefulla påståenden i litteraturen och markerade de 
kunskapsluckor som måste fyllas för att ytterligare förbättra människors hälsa. 
 
Nyckelord: enzymvilkor, flödesanalys, tumör, Warburgeffekten, Crabtree-effekten, laktattröskeln, sinade 
metaboliter, hämmad tillväxt, cellulär ekonomi, förbikoppling. 
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Background 
The cell is the fundamental unit of life. By improving our understanding of the cell, we may 
improve quality of life through a wide range of applications, from drug development to production 
of bio-based goods and services. The increasing availability of biological data allows us to ask more 
detailed scientific questions about the functions of cells under different conditions. Computer 
models help us to put the data in context of our collective knowledge and enable quantitative 
predictions of phenotypes through simulations. The models provide mechanistic descriptions of 
cellular behavior, founded in biophysical constraints and the theory of evolution. In this thesis, I 
developed metabolic models of yeast, infants, exercising humans and cancer. I use the models to 
simulate growth and ATP synthesis and interpret the predictions. 
Understanding and improving life 
We can improve life by modifying cells. All living organisms are made up of cells and are affected 
by changes at the cellular level. Cellular interventions may sometimes be desirable in order to cure 
a disease or improve the productivity of cells of industrial relevance. In the case of disease 
treatment, cells are reverted from a diseased to a healthy state through some type of intervention. 
Some diseases develop from malfunctioning cells, and may be treated with small molecule drugs 
that enter the cell and interact with its constituents (Adams et al. 2015). Others arise from 
malnutrition, and may be prevented by appropriate nutritional interventions (Prendergast & 
Humphrey 2014). Yet other diseases are caused by infections, and require the pathogen to be 
separated from the host (Bordbar & Palsson 2012). In the case of industrially relevant cells, they 
may be modified to increase productivity or to yield new types of products through metabolic 
engineering. An example is yeast, which traditionally has been used in baking, brewing, but has 
been modified to produce chemicals in several industrial fermentation processes (Nielsen 2015). 
To be able to modify cells with reliable results, a fundamental understanding of the cell is required. 
Cells are at their core self-replicators that must divide to grow. The growth of cells is the result of 
complex interactions between a number of biological processes (Molenaar et al. 2009). Many of 
which may limit growth, e.g. DNA replication, synthesis of proteins and uptake of nutrients. 
Environmental factors such as substrate availability, temperature and stress factors may also play 
a role. In the case of multicellular organisms, the growth of cells is constrained by regulatory signals 
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(Hanahan & Weinberg 2011). Careful control of cell growth is required to maintain the organism 
in a healthy state.  
Different diseases and syndromes are caused by malfunctioning growth processes. One example 
is cancer, it is a disease that involves uncontrolled cell growth and is estimated to cause 9.6 million 
deaths in 2018 (Bray et al. 2018). Mutations, and other genetic events, reprogram the cancer cells 
to avoid checkpoints in control of nutrient supply and growth (Hanahan & Weinberg 2011).  
Another example is the stunting syndrome, it involves reduced growth in children, and affects 165 
million children younger than 5 years globally. It is associated with decreased cognition and health 
(Prendergast & Humphrey 2014). Since the human body is a complex system, examining cells in 
isolation may sometimes be more informative. 
We can understand human cells better by studying other organisms. Due to the shared evolutionary 
history, similar principles may be used to understand disparate biological systems (Liu et al. 2014). 
The generalization of knowledge from one species to another may be illustrated by model 
organisms. These are less complex organisms that are easier to study, and for which more prior 
knowledge is available. Many discoveries in the model organism Saccharomyces cerevisiae, have later 
been translated to human (Hohmann 2016), e.g. discoveries related to cell division, protein 
transport and DNA protection by telomeres. A detailed understanding of the cell has emerged 
from studying, yeast and other model organisms. 
Metabolism is the base, signaling the superstructure 
Metabolism controls the cell. Cellular activities may be broadly divided into metabolism and 
signaling (Hyduke & Palsson 2010). Metabolism is the base and carries out the physical activities 
of the cell. It is central to their maintenance and growth. It converts nutrients into building blocks 
and free energy in the form of ATP through a vast network of enzyme mediated biochemical 
reactions. Signaling is the superstructure and carries out the decision-making activities of the cell. 
It regulates metabolism through the activities and abundances of enzymes. The signaling network 
responds to changes in the environment and to the new metabolic requirements that follow, e.g. 
depletion of a growth enhancing metabolite. It also carries out the internal dynamics of the cell, 
e.g. the progression through the cell cycle. The physical limitations of metabolism shape the 
signaling system, and the signaling system maintains metabolism in an appropriate form.  
The cell must optimize its allocation of protein. Biological processes require enzymes and other 
proteins to function. The protein content of the cell is finite, and the cell must therefore optimize 
the allocation of proteins amongst these functions. This becomes a regulatory problem for the cell, 
i.e. the protein allocation problem. A concept that has been popularized through different versions 
of proteome fraction models (You et al. 2013; Hui et al. 2015; Mori et al. 2016). They divide the 
protein pool into different coarse-grained sectors such as core functions, the ribosomes and 
metabolism. The growth condition dictates the optimal allocation between these sectors. By 
definition, the core functions are assumed to cover housekeeping activities that are independent 
of growth. The demand for ribosomes is thought to be a simple linear function of the specific 
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growth rate. This leaves most of the dynamics to the metabolic domain. The protein allocation 
problem gives rise to trade-offs between different metabolic strategies. 
Overflow metabolism is a trade-off between efficiency and rate. It denotes a shift in ATP synthesis 
strategy from respiration towards fermentation while under aerobic conditions (Molenaar et al. 
2009). This results in increased consumption of substrate, e.g. glucose, and the excretion of 
fermentation products, and thus a lower yield of ATP per substrate. The catalytic rate of 
fermentation is however higher, and more ATP can thus be synthesized per enzyme mass. This 
makes overflow metabolism a favorable metabolic strategy under conditions when rapid ATP 
synthesis is required. The phenomenon occurs in many organisms under different names, the 
Crabtree effect in yeast, the Warburg effect in cancer, the lactate threshold in sports (Molenaar et al. 2009; 
Vazquez & Oltvai 2011). Analogous low-yield pathways also exist in many bacteria, e.g. Escherichia 
coli and Bacillus subtilis (van Hoek & Merks 2012). Cancer cells commonly gain access to overflow 
metabolism by dysregulating the cells oxygen sensor HIF-1α (Cairns et al. 2011). The resulting 
high glucose consumption rates can be exploited for tumor detection using positron emission 
tomography, i.e. PET scans. 
Cancer cells modify metabolism to support rapid growth. There are several metabolic traits, aside 
from rapid glucose consumption, that are shared by many cancer cells. The amino acid glutamine 
is commonly consumed at high rates (Wise & Thompson 2010). Several other amino acids are 
instead excreted, e.g. glutamate, alanine and glycine (Zielinski et al. 2017; Jain et al. 2012). It 
remains unclear why cells excrete glutamate (Seidlitz et al. 2009; Stepulak et al. 2014), and despite 
many influential studies on the importance of metabolism for cancer cell proliferation, we are 
missing an overall view of how cancer cells coordinate acquisition of the diverse nutrients required 
for growth (Palm & Thompson 2017). This calls for an integrative study of metabolism in cancer 
using a systems biology approach. 
Computer simulations in systems biology 
Systems biology takes a holistic perspective on the cell (Kitano 2002). It focuses on the interactions 
between the cells components and on the complex behavior that emerges from these interactions. 
This is facilitated by computer models, which integrate knowledge and data into a structured 
framework (Figure 1A). The use of computer models in systems biology may be broadly divided 
into the top-down approach and the bottom-up approach (Bruggeman & Westerhoff 2007). Top-
down systems biology maps experimental data to models to identify phenomenological facts, 
which may in turn be interpreted as molecular mechanisms. Bottom-up systems biology simulates 
molecular mechanisms in silico, i.e. in the computer, and generates quantitative and testable 
predictions of cell behavior. 
Mechanistic relationships in reality may be inferred from the simulations. The simulated interaction 
between the components of a model can be interpreted as a mechanistic relationship in silico, e.g. 
knocking out a certain gene causes a reduction in cell growth. This relationship in the model may 
then be translated to statements about reality, if the correspondence between the model and reality 
is considered to be sufficiently good. The predictions do, however, always have an implicit 
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dependency on the accuracy of the model structure and the parameter values. In the absence of 
complete information, predictions can also be informative (Gutenkunst et al. 2007). They may 
show that a property is predictable in principle under more favorable research conditions, e.g. in 
the case of random sampling of parameter values and ensemble modeling (Morris et al. 2016; Tran 
et al. 2008; Beg et al. 2007; Steuer et al. 2006). In the absence of detailed parameter data only 
general conclusions may be drawn about a system of interest. 
A good model should describe the quantitative state of a cell under a condition of interest. The 
state refers to the quantities of the components of interest, e.g. concentrations of metabolites and 
enzymes or metabolic fluxes. The state may have time dynamics or be in steady state. By definition 
a cell has a single state at a given point in time, but many states may exist within a population of 
cells (Labhsetwar et al. 2017). A common abstraction is to assume that all of the studied cells are 
in a single representative steady state. Some properties of the cells may be directly quantified 
experimentally, e.g. the concentration of proteins and metabolites. Other properties are 
abstractions which cannot be directly observed, e.g. the specific metabolic fluxes (Winter & 
 
Figure 1. The relation between model and reality in systems biology. A) A good model has an injective relationship 
with reality, which allows mechanistic relationships in the model to be directly mapped to reality (mechanistic 
inference). Data is gathered about reality through experiments (green arrows). These may be aimed at identifying 
parameter values that are invariant to time and the condition. They may also be used to give an experimental 
account of the state of the cell. Bottom-up systems biology (orange arrows) constrains models with parameter values 
to make experimentally veriﬁable predictions. Top-down systems biology (blue arrows) integrates experimental data 
to ﬁt a model. The ﬁtted model may potentially be used to estimate parameters and thus allow bottom-up systems 
biology. B) The biophysical constraints on a cell generate a ﬁtness landscape, which may have some global optimum. 
Evolutionary processes drive the cells towards optimality. Assuming that cells have reached near optimality, the 
state of the cell may be predicted from the ﬁtness landscape. Experimentally derived constraints may be used to 
rule out possible but counterfactual states. 
★
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Krömer 2012). A well calibrated model overcomes these limitations, and allows a non-disruptive 
assessment of the state of the system. This may be particularly useful if the physical integrity of 
the system is important, as in the case of humans. 
Constraint-based modeling of biology has been a fruitful paradigm (Orth et al. 2010; Palsson 2015). 
Biological knowledge can often be expressed in the form of constraints. The knowledge may be 
derived from experiments, e.g. the observed glucose uptake rate under a condition of interest.  It 
may also be derived from biophysics, e.g. that the catalytic capacity of an enzyme does not exceed 
some value. The biophysical constraints form a fitness landscape for the cell (Figure 1B). The state 
of the cell may be predicted from the interaction between the biophysical constraints on the cell 
and the evolutionary drive towards optimality, the theory of dual causality (Bock 2017; Palsson 
2015). Using this theory, the model may be able to explain the rationale behind an observed cellular 
phenomenon, e.g. the cell prefers to consume glucose because it can consume it faster than other 
sugars. It should be noted that many biophysical constraints arise from the physical properties of 
enzymes, and may be subject to change on an evolutionary time scale (Savir et al. 2010).  
Constraint-based modeling of metabolism 
Different types of metabolic models exist. They primarily fall into the categories of topological, 
stoichiometric and kinetic models (Steuer 2007). These describe the cell with increasing level of 
detail and hence with increasing demand for parameter values (Figure 2). Topological models 
require little experimental data, but are limited to qualitative predictions about the state of the cell, 
e.g. lethal or non-lethal gene deletions. Dynamic models have the potential to give a detailed 
description of the state of the cell, but due to data availability they are often limited to studying 
subsystems. In particular the enzyme capacity data commonly used as parameter in dynamic 
models (vmax=[E]∙kcat) has an implicit dependency on enzyme concentrations ([E]) that are specific 
to the studied condition (Müller et al. 2015). General conclusions transcending the experimentally 
determined state cannot easily be made. In this thesis I make use of stoichiometric models of 
metabolism. 
A genome-scale metabolic model (GEM) is a mathematical representation of metabolism (Orth et 
al. 2010; Palsson 2015). It contains information about the stoichiometry of (nearly) all biochemical 
reactions in an organism, and links them to the genes that encode for the enzymes in question. 
Thus, genes, metabolites and reactions are joined to form a network (Figure 3A), expressed as a 
stoichiometric matrix (Figure 3B). For multi cellular organisms a multi tissue model can be 
developed by joining several models through a shared compartment (Bordbar et al. 2011). Flux 
balance analysis (FBA), is a method used to predict the metabolic fluxes of the reactions under a 
condition of interest (Figure 3C). Metabolites are assumed to be well mixed and at a constant 
concentration within each cellular compartment. This relies on the steady state assumption, i.e. 
that fluxes producing and consuming each metabolite cancel out, preventing buildup or depletion 
of internal metabolites. 
FBA integrates constraints with the model. Experimental data can be integrated in the form of 
flux bounds and constraints, e.g. measurements of exchange fluxes and the accumulation of 
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biomass. Alternatively, constraints may be added based on prior knowledge, e.g. enzyme pool 
constraints. Models constrained with experimental data are, by construction, limited to describe 
the state for which the data was collected. Models with biophysical constraints may be generalized 
to any condition for which the biophysical description is valid. The addition of experimental and 
biophysical constraints is seldom sufficient to uniquely determine the fluxes, resulting in a large 
solution space. For the biophysically constrained models this can be interpreted as a high degree 
of metabolic flexibility being retained by the cells. 
Fluxes are predicted by solving an optimization problem. To identify a quantitative and unique 
flux prediction, the cells are assumed to (successfully) optimize some objective function (Orth et 
al. 2010). This is done by solving a linear programming problem that optimizes the flux through 
the affiliated reactions (Figure 3C). For growing cells, this may be to maximize the specific growth 
rate, and for non-growing cells, this may instead be to make efficient use of limited resources, by 
minimizing the substrate consumption. The living cell may have other priorities than maximizing 
growth. One proposed trade-off is between efficiency and the robustness to perturbations of 
metabolism (Segrè et al. 2002; Stelling et al. 2002). Another trade-off may be between accuracy and 
efficiency; for the ribosomes fast processing of mRNAs comes at the price of more mistranslation 
(Johansson et al. 2012). However, in some cases adapting the organism to the laboratory 
conditions, will drive the phenotype closer to the predicted optimum (Lewis et al. 2010). Multiple 
optimal solutions often remain after the first optimization, and a second optimization is often run 
to identify a minimal flux vector (Raman & Chandra 2009). This process may be viewed as a proxy 
for minimizing enzyme usage, but may not always be reliable, since all reactions carry equal weights. 
 
Figure 2 Diﬀerent types of metabolic models. Diﬀerent metabolic models may be suitable depending on the 
research question. Topological models require little experimental data and can give qualitative predictions about 
ﬂuxes and essentiality of genes. Stoichiometric models require quantitative constraints to make quantitative ﬂux 
predictions. Kinetic models give dynamic ﬂux predictions, but rely on a large number of parameter values. This 
typically reduces the scope of the models to the level of pathways, and the parameters used are often speciﬁc to a 
particular context. 
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Enzyme-constraints integrate FBA with the protein allocation problem. Enzyme-constrained 
metabolic models attempt to account for the protein investment required to sustain metabolic 
fluxes (Molenaar et al. 2009; Müller et al. 2015). They account for the constraints posed by limited 
enzyme capacities and have been used to model the processes underlying phenotypes in several 
organisms. The models have improved our understanding of constraints on the maximum specific 
growth rate for different organisms (Adadi et al. 2012), the diauxic shift (Beg et al. 2007) and 
overflow metabolism (Vazquez & Oltvai 2011; Shlomi et al. 2011). They come in the form of 
Figure 3. Genome-scale metabolic modeling using ﬂux balance analysis. A) A metabolic network is reconstructed 
and experimental data on boundary ﬂuxes are gathered, alternatively, parameter data is gathered for the relation 
between ﬂuxes and enzymes. B) The network is represented by a stoichiometric matrix (S) where the rows 
correspond to metabolites and columns to reactions. Each reaction is represented by assigning the stoichiometric 
coeﬃcients of the participating metabolites to the corresponding rows, where negative values indicate consumption 
and positive values production. C) Simulations are conducted to predict the ﬂuxes (v), expressed in mmol per gram 
dry cell weight per hour (mmol/gdw/h). The simulations assume that metabolite concentrations are in steady state. 
Fluxes are constrained by upper and lower bounds (ub and lb) from experimentally determined intervals, when 
available. For irreversible reactions the lower bound is set to zero (lb=0). Alternatively or additionally, the ﬂuxes are 
constrained through their use (w) of a constrained pool of total enzyme (P). A ﬂux distribution is sought that 
optimizes the ﬂux through one or more reactions (c), e.g. maximizes growth. There are often multiple ﬂux 
distributions that result in the same optimal solution. The distributions often contain large predicted ﬂuxes due to 
loops in the model. A second optimization is therefore often run to reduce unnecessarily large ﬂuxes and remove 
loops. The absolute value of all ﬂuxes is minimized, whilst maintaining the optimal solution. This results in a vector 
with the same ﬂux through the objective function but with the lowest sum of absolute values of ﬂuxes i.e. the 
minimum L1 norm. This is referred to as parsimonious FBA (pFBA). 
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constraints from macromolecular crowding (Beg et al. 2007), constraints on the sum of enzyme 
mass (Adadi et al. 2012) or on crowding of membranes (Zhuang et al. 2011; Szenk et al. 2017). 
Several metabolic models aspire to expand these constraints further to balance all of the resources 
in the cell, e.g. resource balance analysis (Goelzer et al. 2011), models linking metabolism to protein 
expression (O’Brien & Palsson 2015), models using proteome sectors (Mori et al. 2016) and whole 
cell models (Karr et al. 2012). We have only begun to discover the prediction power of resource-
constrained models. 
Aim and significance 
Millions of people are affected by severe health issues. To reliably revert unhealthy cells to a healthy 
state, we must understand the healthy cell on a fundamental level. Growth is a core property of 
the healthy cell, and diseases often emerge when cells diverge from a healthy growth pattern. 
Metabolism supplies the materials and free energy required for growth. It is constrained by the 
biophysical properties of the enzymes involved, and complex behavior arises from the cells 
adaptations to the constraints. By simulating metabolism using mathematical models, we can gain 
an understanding of these processes. In this thesis I aimed to advance our fundamental 
understanding of cells, with implications for human health. I focused on mechanistic models of 
processes involved in growth and ATP synthesis. I was particularly interested in how biophysical 
constraints shape the fitness landscape of the cell and how phenotypes emerge from the cells’ 
attempts to optimize metabolic fluxes. Much work has already been done in this area and 
preexisting methods and models were modified to improve their scope and quantitative accuracy. 
In this thesis (Paper I), I conducted the first genome-scale metabolic simulations of growth in a 
healthy infant. Several mathematical models of infant growth have been developed in the past 
(Fjeld et al. 1989; Butte 2005; Jordan & Hall 2008). These models do, however, not explicitly model 
the metabolic fluxes of the cells. I took a data driven (top-down) approach to characterize the 
metabolic state of the infant. Various published datasets were integrated to estimate the metabolic 
fluxes and the growth rate. I found that growth was primarily constrained by the ATP synthesis 
requirements, which justifies the assumptions of the preexisting models.  
In this thesis (Paper II), I conducted the first genome-scale metabolic simulations of a cancer cell 
line constrained with data from a dedicated experiment. There already exist several genome-scale 
metabolic models of cancer cells (Shlomi et al. 2011; Agren et al. 2012; Agren et al. 2014), as well 
as models of other mammalian cell types, e.g. hepatocytes (Mardinoglu et al. 2014), adipocytes 
(Mardinoglu et al. 2013), myocytes (Väremo et al. 2015), hybridoma cells (Sheikh et al. 2005) and 
CHO cells (Martínez et al. 2012). However, metabolic models of cancer that make use of 
experimental data have been limited in scope (Fan et al. 2013; Fan et al. 2014; Zielinski et al. 2017; 
Quek et al. 2014). There are several reasons for this. There are documented problems with model 
consistency for some genome-scale models (Swainston et al. 2016). Many popular algorithms and 
methods cannot be applied to genome-scale models (Erdrich et al. 2015). And it may be easier to 
interpret the results of a smaller model.  Here I expanded the scope of cancer simulations to the 
genome-scale with a model that included multiple cellular compartments. This was instrumental 
to explain why cancer cells excrete glutamate.  
9 
When I integrated the experimental data on metabolite concentrations I noticed that some 
metabolites had been depleted before the experiment was completed. I therefore developed 
methods to account for depletion events in an appropriate way. I expected that other studies also 
may have encountered metabolite depletion. In this thesis (Paper III), I reanalyzed the data from 
a published high throughput flux characterization experiment  (Jain et al. 2012). The reanalysis 
showed that growth enhancing metabolites had been depleted before the samples were taken in 
many of the cell cultures. This appears to have both qualitative and quantitative effects the 
characterized fluxes. 
In this thesis (Paper IV), I developed the first fully parameterized enzyme-constrained (bottom-
up) model of intermediary metabolism in yeast. Several metabolic models with enzyme constraints 
exist for E.coli (Beg et al. 2007; Adadi et al. 2012) and yeast (van Hoek & Merks 2012). However, 
these models either rely on randomly sampled parameter values, or are only partially parameterized 
with experimental values. By limiting the scope of the model to intermediary metabolism, and 
employing extensive search in literature and databases, it was possible to assemble a complete set 
of kinetic parameters. The model showed an increased use of glycolysis at high ATP synthesis 
rates, i.e. overflow metabolism, thus corroborating the hypothesis that fermentation has a higher 
catalytic efficiency than respiration. From the simulations it was possible to infer that the low 
efficiency of F1FO-ATP synthase was the most influential biophysical constraint behind the 
phenomenon. The model was later expanded to the genome-scale level in another project (Sánchez 
et al. 2017).  
In this thesis (Paper V), I developed a fully parameterized enzyme-constrained (bottom-up) model 
of intermediary metabolism in human muscle. Several metabolic models with enzyme constraints 
exist for human (Shlomi et al. 2011; Vazquez & Oltvai 2011). However, these model are only 
partially parameterized. The fully parameterized model enabled a more detailed analysis of the 
constraints involved in ATP synthesis. Unlike yeast, human muscles do not have time to adjust 
their proteome during ATP synthesis. By integrating protein abundance measurements with the 
enzyme parameters, more realistic constraints were calculated for the fluxes. Phenotypes of 
multicellular organisms depend on the metabolic interaction between multiple cell types. I 
therefore expanded the model to a multi-tissue model. Previous multi tissue models of human 
(Bordbar et al. 2011) do not use enzyme-constraints, and were not used to study exercising 
humans. 
The use of enzyme-constrained models relies heavily on parameter values from literature. In this 
thesis (Paper VI), I proposed that a systematic characterization of all kinetic parameter values, i.e. 
the kinetome, is necessary for enzyme-constrained models to reach their full potential.  
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Methods 
Genome-scale metabolic modeling of growth using flux balance analysis is a well-established 
method (Palsson 2015; Orth et al. 2010). It relies on a metabolic network with a biomass equation. 
The use of interior constraints, e.g. enzyme capacity constraints, enables quantitative predictions 
under a condition of interest. If such constraints are not available, or are deemed too imprecise, 
experimentally derived boundary constraints may be used to predict the flux state of the cell. 
Sensitivity analysis may then be used to infer the relative importance of the fluxes and predict the 
effects of perturbations. 
Network reconstructions and the biomass equation 
The metabolic network is central to a GEM. Community efforts have resulted in several generic 
metabolic models of human and yeast (Mardinoglu et al. 2013; Brunk et al. 2018; Förster et al. 
2003). These models can be reduced to a model of a cell type or a tissue by removing reactions 
without support in transcriptomics or proteomics data (Agren et al. 2014; Agren et al. 2012). 
Additional manual curation is often required, and the models are commonly reduced in size to give 
a more manageable set of reactions (Zielinski et al. 2017; Quek et al. 2014). For simulations of 
human in this thesis (Paper I, III, V), the networks originated from the generic human 
reconstruction, HMR 2.0 (Mardinoglu et al. 2013). A multi-tissue model (Paper V), was also 
constructed for different muscle tissue types, based on a reconstruction of the myocyte (Väremo 
et al. 2015). For simulations of yeast (Paper IV), I use a reduced version of the iFF708 
reconstruction (Förster et al. 2003; Agren et al. 2013). The biomass equation is a crucial component 
of metabolic models designed for quantitative flux predictions. 
The biomass equation contains all the components required to synthesize a cell (Figure 4A), e.g. 
proteins, lipids, nucleotides and glycans. It is an artificial reaction which acts as a sink for the fluxes 
and has a different unit (gdw/gdw/h) than the other fluxes (mmol/gdw/h). Its stoichiometric 
coefficients therefore contains an implicit change of units (gdw/mmol). The full biomass equation 
contains a large number of metabolites and it may therefore be convenient to split it into sub 
modules. For small-scale models, few of the biomass components are in the metabolite list. In this 
thesis (Paper IV) the drain of metabolites required for growth in a small-scale model was identified 
based on simulations in a genome-scale model (iFF708). The protein fraction is normally the 
dominating component in the biomass equation (by mass). The amino acid composition of the 
protein fraction must be known to accurately represent it. In this thesis (Paper II) this was 
estimated using protein abundance data and the amino acid frequencies of the proteins. 
A cells composition depends on the growth rate. The biomass composition and the ATP 
requirement for growth are often taken as constant. However, in the living cell they commonly 
depend on the growth rate (Dikicioglu et al. 2015). This is thought to influence the model 
predictions. In this thesis, condition dependent biomass equations were used. For the infant 
simulations (Paper I), the age dependent fat fraction in newly formed biomass was estimated from 
body composition data (Figure 4B). The energy requirement for growth was dynamically calculated 
from the composition, 5.5 kcal/g protein and 1.6 kcal/g fat. For the yeast simulations (Paper IV), 
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experimental data was used to adjust the biomass equation to the growth rate. The ATP 
expenditure required for growth was also adjusted depending on the growth rate to stay consistent 
with the rates calculated from exchange fluxes. 
Metabolites are diluted in growing cells. It is reasonable to assume that the metabolite 
concentrations of the cell fluctuate around some mean value. However, the steady state assumption 
neglects the dilution term associated with growth (Benyamini et al. 2010; Dikicioglu et al. 2015). 
When the mass of cells double, so must all metabolites to avoid depletion. Since the flux over most 
metabolite pools is much larger than the dilution of the pools, this assumption has limited effect 
for most predictions. But as the precision of simulations improve, the effect could become 
noticeable. The problem may be overcome by adding the metabolite pool to the biomass reaction, 
or adding dilution coefficients to each reaction. In this thesis I added the metabolite pool to the 
biomass reaction (Paper II) or neglected the dilution term altogether (Paper I, IV). 
The wide range in concentrations of the biomass components may cause numerical issues for the 
computer. The optimization problem in FBA is solved by a linear programming algorithm. These 
algorithms commonly rely on floating point arithmetic (numbers are expressed as a significand and 
a base), which is a compromise between precision and range. Since the significand is expressed 
with a limited number of bits, rounding errors may occur when applying some arithmetic 
operations, e.g. division, and some values, e.g. 1/3, cannot be represented exactly. The use of LP 
solvers for FBA problems has been criticized, with the argument that the rounding errors may 
result in incorrectly predicted feasibility (Chindelevitch et al. 2014). An alternative is to use an 
algorithm with rationals (Applegate et al. 2007), but this is normally slower than to increase the 
precision of the solver. The magnitude of the (non-zero) values in the solution to a FBA problem 
may span 11 orders of magnitude. The upper bound of the fluxes is 103 by default and the lowest 
flux is typically given by the concentration of a metabolite in the biomass equation multiplied with 
 
Figure 4. Composition and dynamics of the biomass equation. A) The biomass composition of a liver cancer cell line 
was assembled from literature sources. B) The fat fraction in newly synthesized infant tissue is a function of age. 
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the growth rate. Metabolite concentrations may be as low as 10-6 (Park et al. 2016), and a typical 
growth rate is around 10-2. In this thesis (Paper II), metabolites with a concentration lower than 
10-4 were removed to retain fast solutions and avoid numerical issues. 
Interior constraints, enzyme-constrained models 
Interior flux constraints are useful to understand the behavior of cells. These constraints may come 
in the form of experimentally derived flux capacities (v≤vmax). These capacities may be calculated 
(vmax=[E]∙kcat) from enzyme parameters and abundance data (Sánchez et al. 2017).  It is possible 
to identify which of the interior constraints are active under the studied condition, i.e. which fluxes 
are equal to the constraint (vi=[vmax]i). These constraints are condition specific since they are 
experimentally derived, and may not necessarily reflect a global constraint. In this thesis (Paper 
V), I make use of interior flux constraints calculated from experimental data. 
The internal fluxes may also be constrained by a limited enzyme pool (Figure 5). The enzyme 
requirement for each metabolic flux (vi) is estimated by multiplication with a weight (wi). Models 
with enzyme pool constraints enable simulations of resource allocation. The predicted reallocation 
of enzyme abundances between conditions is thus a predictor of metabolic regulation. Since the 
enzyme abundances are not fitted to a particular condition these models reflect global constraints 
on growth. Various nutritional conditions may be simulated by opening or closing the boundary 
fluxes. This results in different metabolic strategies (A, B, …), which may be referred to by their 
corresponding flux vector (vA, vB, …). The catalytic efficiency of the strategies may be compared as wT(vA- vB)≤0. By applying elasticity analysis to the weights, their relative contribution to the 
efficiency of a strategy may be investigated. In this thesis (Paper IV, V), I examined the constraints 
on ATP synthesis and growth using enzyme pool constraints. 
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Figure 5. Enzyme-constrained models. A) The concentration of an enzyme ([E]) required for a flux (v) depends on 
the turnover rate of the enzyme (kcat) and the degree of enzyme saturation. A direct relationship between flux and 
enzyme requirement can be calculated (dashed line), assuming Michaelis–Menten kinetics and a substrate 
concentration ([S]) equal to the Michaelis constant (KM). B) The model must be converted to an unsigned format to 
ensure that all fluxes are positive. The matrix S is multiplied with -1 and concatenated with S. Lower bounds are set 
to zero for all fluxes and the upper bounds for the concatenated matrix are set to -1 times the lower bound. C) An 
enzyme pool constraint is added. A vector of weights (w) may be calculated for each reaction (i) to translate flux to 
the required enzyme mass concentration. To calculate the weights, the enzyme saturation (u) must be estimated. 
Sensitivity analysis with boundary constraints 
Metabolic models with boundary constraints make predictions about the interior fluxes. These 
constraints are empirical, not biophysical, and the observed boundary fluxes arise from interior 
constraints in one, several or all reactions. To make predictions about counterfactual states, e.g. 
the predicted maximum growth rate on a different carbon source, the fluxes must be translated to 
constraints. Elasticity analysis (Figure 6A) estimates the effect on growth from perturbations in a 
flux �Evµi�. The predicted flux is taken as reference, and the flux is scaled by some arbitrarily lower 
value (1-ε) and constrained. The growth in the perturbed state (µi) is compared with non-
perturbed growth (µ). 
𝐸𝐸𝑣𝑣
µ
𝑖𝑖
= 1 − µ𝑖𝑖�µ
𝜀𝜀
Growth is expected to be sensitive to perturbations in reactions with active constraints. But a high 
predicted sensitivity does not necessarily imply an active constraint. The predicted flux may reflect 
parsimonious nutrient utilization by the cell and the enzyme may have plenty of excess capacity, 
or may be regulated to provide this. 
The predicted sensitivity of many reactions is often low due to redundant pathways. These 
pathways may however not always be physiologically relevant, e.g. the flux capacity of the pentose 
phosphate pathway may be insufficient to circumvent a block in glycolysis. The predicted flux 
through a reaction under a favorable condition is a rough estimate of the effective vmax of the 
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reaction. A conservative approach may then be to use all predicted fluxes as capacity constraints 
(Figure 6). Although this is expected to prevent non-physiological rerouting, it may also prevent 
physiological rerouting. It can therefore be thought of as the acute adaptation to a perturbation, 
and later the flux landscape may be remodeled by transcriptional and regulatory changes. In this 
thesis (Paper II), this type of acute sensitivity analysis (ASA) was applied to study inhibition of 
glycolysis and other ATP synthesizing pathways. 
From the optimality assumption, it is expected that growth should be sensitive to perturbations in 
all reactions. In practice this may not be the case since some fluxes are forced to fit experimental 
data. If the fluxes are small this may reflect experimental error, but if they are substantial, this may 
instead indicate an incomplete description of the objective of the cell. In this thesis (Paper II), I 
identify instances of this type of flux. 
reaction inhibition
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Results 
In this thesis, I study ATP synthesis and growth in computer models of yeast and human. The 
models of infant and liver cancer used boundary constraints to predict the maximum specific 
growth rate and to estimate the interior fluxes. The models of yeast and muscle used interior 
constraints to study metabolic trade-offs and the maximum metabolic capacity on different 
substrates. The different models operated at specific growth rates and ATP synthesis rates that 
differed by orders of magnitude. This affected their responses to perturbations in energy 
metabolism. Nevertheless all models showed increased utilization of glycolysis at high ATP 
synthesis rates. Overflow metabolism from glycolytic substrates to fermentation products was 
found to be an efficient metabolic strategy. The cancer cells also excreted glutamate. The 
simulations related this to compartmentalization of glutamate metabolism.  
Constraint-based models of metabolism 
Simulations of metabolism were conducted in four different models, an infant, a cancer cell line, 
yeast and muscle. A model of high quality is a requisite for causal inferences. In this section I 
present the models together with some fundamental quality measures and principal results. In the 
next section I then proceed to analyze the phenotypic predictions arising from the models. 
Growth of an infant on breastmilk (Paper I) 
Healthy infants more than double their weight during their first 6 months in life. Growth may be 
challenged by complications in retention or availability of nutrients (Prendergast & Humphrey 
2014). In severe cases, stunting syndrome may develop, i.e. very short length for the age. This 
primarily occurs in developing countries, and cost-efficient interventions would therefore be 
advantageous. Metabolic models provide insight on constraints on growth with reaction-level 
resolution. However, current models of infants (Fjeld et al. 1989; Butte 2005; Jordan & Hall 2008) 
do not explicitly model the metabolic fluxes. The relatively high growth rate, the uniform diet, i.e. 
breastmilk, and the abundance of experimental data make infants suitable for metabolic modeling.  
A model of the growing infant was reconstructed. It was based on the HMR 2.0 model, which was 
modified to include age dependent reactions for biomass synthesis, energy expenditure and 
nutrient uptake. The biomass of the infant was broadly classified as fat and lean mass, which was 
represented by the free fatty acid composition and the amino acid composition of infant. The fat 
fraction in newly formed biomass decreased from around 40% during the first 3 months to around 
25% at month 6 (Fields et al. 2011). The energy expenditure of the infant involved the 
requirements for growth, maintenance and physical activity and depended on body composition 
and age. The uptake of nutrients by the infant was calculated from the age dependent metabolite 
composition of breast milk and the daily intake rates  (Butte et al. 2002; Hester et al. 2012; 
Yamawaki et al. 2005; Peng et al. 2007), and was used to constrain the boundary fluxes. Growth 
was then simulated by maximizing the synthesis of biomass. 
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Figure 7. Growth of the infant during the ﬁrst 6 months. A) The predicted growth for the infant model depends on 
the energy expenditure. Growth trajectories with normal, high and low energy expenditure was compared to 
reference data (World Health Organization 2009) at diﬀerent percentiles (5,25,50,75,95). The simulations assumed 
that there was no compensatory increase in breastmilk intake. B) The predicted growth of infants was sensitive to 
mineral deﬁciencies. The growth eﬀects were simulated for a 5% reduction in ﬂux through reactions that depend on 
various mineral cofactors. Several predicted weights were below the 25-50th percentile in reference data (shaded 
gray area). C) The mean absolute ﬂux in diﬀerent pathways at increasing ages, normalized by the highest value in 
each pathway. 
Age [months]
Age [months]
0
5000
10000
15000
W
ei
gh
t [
g]
Reference Data
Normal
Low
High
Beta oxidation of unsaturated fatty acids (n-7) (mitochondrial)
Carnitine shuttle (peroxisomal)
Beta oxidation of unsaturated fatty acids (n-9) (mitochondrial)
Beta oxidation of even-chain fatty acids (mitochondrial)
Butanoate metabolism
Carnitine shuttle (mitochondrial)
Carnitine shuttle (cytosolic)
Fatty acid activation (cytosolic)
Tryptophan metabolism
Tricarboxylic acid cycle and glyoxylate/dicarboxylate metabolism
Oxidative phosphorylation
Transport, mitochondrial
Artiﬁcial reactions
Exchange reactions
Transport, extracellular
Beta oxidation of di-unsaturated fatty acids (n-6) (mitochondrial)
Galactose metabolism
Pyrimidine metabolism
Pyruvate metabolism
Glycolysis / Gluconeogenesis
Beta oxidation of even-chain fatty acids (peroxisomal)
Fatty acid transfer reactions
Fat Uptake
ROS detoxiﬁcation
Omega-6 fatty acid metabolism
Cholesterol metabolism
Valine, leucine, and isoleucine metabolism
Lysine metabolism
Histidine metabolism
Cysteine and methionine metabolism
Sulfur metabolism
Bile acid biosynthesis
Folate metabolism
Alanine, aspartate and glutamate metabolism
Arginine and proline metabolism
Phenylalanine, tyrosine and tryptophan biosynthesis
Nicotinate and nicotinamide metabolism
Biopterin metabolism
Propanoate metabolism
beta-Alanine metabolism
Glycine, serine and threonine metabolism
Transport, peroxisomal
Starch and sucrose metabolism
Omega-3 fatty acid metabolism
Pentose phosphate pathway
Pentose and glucuronate interconversions
Nucleotide metabolism
Miscellaneous
Fatty acid biosynthesis (even-chain)
Fatty acid desaturation (even-chain)
Acyl-CoA hydrolysis
Fatty acid elongation (even-chain)
Purine metabolism
A B
C
Age [months]
0.85
0.9
0.95
1
re
la
tiv
e 
w
ei
gh
t
3.3 kg 7.9 kg
7.8 kg
7.2 kg
7.1 kg
6.9 kg
-zink
-copper
-iron
-magnesium
healthy
0 1 2 3 4 5 60 1 2 3 4 5 6
0 1 2 3 4 5 6
0
0.5
1
17 
 
Growth was found to be energy limited. The predicted growth was in good agreement with 
reference data (Figure 7A). The growth rate was constrained by the intake of one or several 
different types of nutrients, the model was used to identify which was the active constraint. Some 
amino acids cannot be synthesized by the body, i.e. essential amino acids, and must be provided 
by the diet. Some fatty acids are also essential. The total intake of nitrogen must be sufficient to 
cover the synthesis of non-essential amino acids and nucleotides. Finally, the intake of nutrients 
for ATP synthesis may be limiting, i.e. calorie restriction. The sensitivity analysis revealed that 
growth was energy limited, this could be illustrated by removing the maintenance energy 
requirement. If other factors than energy were limiting, growth would not increase in this 
hypothetical scenario. However, the predicted weight more than doubled. Additionally, a small 
increase (20%) in maintenance expenditure was sufficient for the predicted weight to drop below 
the 5th percentile within 6 months. Other factors than nutritional may still influence growth. 
Simulated mineral deficiencies decreased growth. Mineral deficiencies are known to cause growth 
defects in animals, and have been investigated as a cause of stunting (Yang et al. 2012; Castillo-
Duran & Uauy 1988; Hill et al. 1983). I therefore investigated how mineral deficiencies could affect 
growth in the infant. Annotation data from a protein database (Bateman et al. 2017) was used to 
identify sets of reactions that shared the same mineral as a cofactor. The flux through these 
reactions was then reduced to 95% of the optimal flux. Cofactors that were involved in energy 
metabolism had the strongest predicted effects on growth (Figure 7B). This was an expected result 
based on the high sensitivity of growth to perturbations in energy metabolism at low specific 
growth rates. Reducing the flux further resulted in infeasible solutions at the later ages due to an 
insufficient capacity to synthesize ATP, to meet the maintenance requirement.  
The model predicted the interior fluxes of the infant. The changes in flux in different subsystems 
were predicted over time (Figure 7C). During the first days they indicated catabolism of amino 
acids, due to insufficient milk intake. Over the first two months they shifted towards biosynthesis 
of fatty acid and metabolism of sugars. And during the last three months, metabolism was centered 
on beta oxidation of fatty acids. This illustrates the capacity of GEMs to provide high resolved 
predictions in time with regards to metabolism. 
Growth of cancer cell lines on medium (Paper II) 
An integrative understanding of metabolism may promote increased cancer survival. Cancer 
survival is currently increasing in developed countries due to implementation best practices and 
management (Bray et al. 2018). But future improvements depend on the development of new 
treatments (Adams et al. 2015). Many human diseases involve reprogramming energy metabolism, 
and it is considered an emerging hallmark of cancer (Hanahan & Weinberg 2011). Cancer 
metabolism is the subject of many models (Shlomi et al. 2011; Agren et al. 2012; Agren et al. 2014; 
Fan et al. 2014; Zielinski et al. 2017), however these are either small in scope or do not make use 
of experimental data. We still lack an integrative view on metabolism in cancer (Palm & Thompson 
2017). Pending questions include: which metabolites are consumed, and at which rates, what is 
their metabolic fate once consumed and why are some metabolites excreted. 
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A model of liver cancer was reconstructed. The model was based on HMR 2.0 with some 
additional manual curation and removal of reactions without support in mRNA sequencing data 
from a liver cancer cell line (HepG2). The biomass equation consisted of 60% protein, 15% 
phospholipids and fats, 12% metabolites, 6% RNA and DNA and 2% glycosaminoglycans. Data 
on protein abundances and amino acid frequencies was used to estimate the amino acid 
composition of the protein fraction. Metabolite abundance data was used for the composition of 
the metabolite fraction.  
The exchange fluxes were charaterized. A liver cancer cell line (HepG2) was cultivated in standard 
growth medium (DMEM). Concentrations of glucose, pyruvate, lactate and most amino acids were 
measured over time. Specific exchange rates were fitted to the data and used as boundary 
constraints for the model. The specific growth rate was predicted by maximizing the biomass. The 
predicted growth was used to calculate metabolite trajectories, and exchange fluxes were refitted 
until both predicted cell counts and metabolite concentrations were in acceptable agreement with 
the experimental data (Figure 8A). Several metabolites were depleted over the course of the 
cultivation, which was expected to affect the magnitude of the fluxes. Unique sets of specific 
 
Figure 8. Growth of a liver cancer cell line (HepG2) on modiﬁed growth medium (DMEM). A) Experimental ﬁts to 
the time dependent changes in metabolite concentrations and cell counts. The data was divided into four metabolic 
phases with diﬀerent speciﬁc exchange ﬂuxes, based on metabolite depletion events. B) The normalized predicted 
ﬂuxes cluster by cell line and growth condition (0, 6 or 22 mM initial glucose) using hierarchical clustering. 
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exchange fluxes were therefore fitted for each growth phase between the depletion events. An 
additional growth phase was introduced at the first hours of cultivation to account for the rapid 
disappearance of several metabolites during this period. To fulfill the carbon balance under this 
phase a protein secretion flux was fitted as an aditional sink for amino acids. 
The predicted fluxes followed an anticipated pattern. Hierarchical clustering (Figure 8B) of the 
predicted fluxes separated the experiments by cell lines and placed similar conditions adjacent to 
each other. Huh7 cells clustered together with the glutamine depleted simulations, reflecting a 
lower dependence on glutaminolysis in this cell line. The fluxes related to biomass synthesis 
constituted a large share of the fluxes and had a similar pattern for all cell lines reflecting the 
differences in specific growth rate. Most fluxes were strictly in the direction defined as forward in 
the model (76%) and only a small set of fluxes (7%) changed direction between conditions. 
Enzyme constraints on growth of yeast (Paper IV) 
Yeast is well suited for metabolic modeling. The yeast S.cerevisiae is a model organism, and can be 
grown under controlled conditions. It is thus well suited to study fundamental question about 
metabolism. There is a rich collection of experimental measurements in different setups available 
in literature, e.g. protein abundances, metabolite concentrations, growth rates and fluxes (de 
Godoy et al. 2008; E Postma et al. 1989; Larsson et al. 1993; Boer et al. 2010). Yeast undergoes 
the Crabtree effect, where cells growing above a critical growth rate switch from pure respiration to 
a mixture between respiration and fermentation. This drastically reduces the yield of biomass on 
glucose, i.e. the amount of biomass produced per glucose consumed. A model of yeast metabolism 
with randomly sampled parameter values had previously demonstrated that this may be related to 
enzyme-constraints (van Hoek & Merks 2012). It remained unclear if these results would persist 
using parameter values from literature, however previous studies in microbes and humans using 
such parameters suggested that predictions may improve (Adadi et al. 2012; Shlomi et al. 2011).  
To study the Crabtree effect, an enzyme-constrained model of yeast was reconstructed. The model 
was based on a small-scale model of intermediary metabolism in yeast (Agren et al. 2013), which 
was reconstructed based on the iFF708 model (Förster et al. 2003). Enzyme constraints were 
incorporated into the model based on parameter values from literature. A vector of conversion 
factors (w) from reaction flux (v) to enzyme mass was constructed. The factors were calculated 
from the reported specific activity of the purified enzymes (µmol/mg protein/min) and an 
assumed saturation. In this case it was assumed that all enzymes operate at half their maximal rate. 
A constraint was introduced such that the sum of mass of the enzymes involved in the model 
(wT|v|) was equal to or less than the observed sum of mass (P) in proteomics measurements, 
around 0.1g/gdw. 
The simulation results were in good agreement with experimental data. The growth of yeast in a 
glucose limited chemostat was simulated (van Hoek et al. 1998). A chemostat is a device where 
cells are cultivated in a tank, fresh medium is supplied at a constant rate (F), and the culture volume 
(V) is held constant by removal of excess volume. The specific growth rate of the cells (µ) then 
becomes equivalent to the dilution rate (µ=D=F/V) at steady state and can thus be experimentally 
controlled. The optimal fluxes at different specific growth rates were simulated by constraining 
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growth and minimizing the specific glucose uptake rate. The predicted exchange fluxes were in 
good agreement with experimental values (Figure 9A). The model could accurately predict the shift 
from respiratory metabolism at low specific growth rates (µ<0.28) to respiro-fermentative 
metabolism at high specific growth rates. In the model this occurred when the predicted sum of 
enzyme mass reached the protein constraint. An empirical constraint on acetate production was 
required to fit the fluxes. 
The models description of NADPH synthesis was incomplete. The excretion of acetate was 
predicted to originate from increased flux through aldehyde dehydrogenase (ALD6). The enzyme 
ALD6 consumes acetaldehyde to produce acetate and NADPH. The increased flux, reflects a shift 
in the strategy for synthesizing NADPH. The exchange of acetate was constrained to the highest 
observed secretion level, to prevent higher synthesis rates than observed. Unconstrained acetate 
production would only have had minor effects on the overall fluxes, but the requirement for an 
empirical constraint indicated that the model of NADPH synthesis at high growth rates was 
incomplete. 
The predictions rely on approximated enzyme abundances. These have been experimentally 
determined during exponential growth in batch conditions (de Godoy et al. 2008). Under these 
conditions, nutrients are available in excess and cells grow at their maximum rate until some 
nutrient is depleted. I simulated exponential growth under batch conditions and the predicted 
enzyme abundances were compared with proteomics data (Figure 9B). The predictions were in 
reasonable agreement with the experimental values, given the crude underlying assumptions. 
Enzymes from the TCA cycle were generally under predicted and oxidative phosphorylation was 
in general over-predicted. This may reflect differences in enzyme saturation, e.g. higher saturation 
in glycolysis compared to the TCA cycle, due to it being a linear pathway. But it may also reflect 
 
Figure 9. Predicted exchange ﬂuxes and protein concentrations for yeast grown on glucose. A) Good agreement 
between predicted (lines) and observed (dots) exchange ﬂuxes at diﬀerent speciﬁc growth rates. The predicted sum 
of enzyme mass (wTv) reaches the protein constraint (P) at a speciﬁc growth rate of 0.28. B) Acceptable agreement 
(Pearson correlation 0.6) between predicted and observed enzyme concentrations, during the exponential growth 
phase. 
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experimental challenges in accurately quantifying proteins that originate from different cellular 
compartments or are attached to membranes. 
Enzyme constraints on the activity of muscle (Paper V) 
Muscles are tailored towards ATP synthesis. In the context of human endurance sports, high 
sustained ATP production is one of the most important competitive advantages (Peronnet & 
Thibault 1989). The working muscle must adjust the rate of ATP synthesis to match the work rate. 
The metabolism of the muscle can thus be experimentally controlled by adjusting the resistance 
(Poole & Richardson 1997). At high exercise intensities the muscles begin to produce lactate and 
there is a trade-off between endurance and power output (Grassi et al. 1999; Peronnet & Thibault 
1989). Previous metabolic models of muscles, make qualitative predictions about these phenomena 
(Vazquez & Oltvai 2011). However these models do not include parameter values for the 
individual enzymes.  
An enzyme-constrained muscle model was reconstructed. A model of intermediary metabolism in 
a muscle fiber was reconstructed from a subset of HMR 2.0. The subset consisted of the reactions 
that remained after removing reactions that did not carry flux when simulating ATP synthesis 
under various conditions, e.g. absence of complex I and V and absence of oxygen. Protein mass 
abundance data (E) and the specific activity (a) of the purified enzymes were used to calculate the 
maximum theoretical flux for each enzyme mediated reaction in the model (vmax=E∙a). The 
reactions were constrained to half the maximum flux to reflect saturation effects. 
The simulations were in good agreement with experimental data. The optimal fluxes for the muscle 
fiber were simulated at different ATP synthesis rates. This was done by constraining the ATP 
synthesis rate and minimizing the specific glycogen depletion rate. The predicted maximum oxygen 
uptake rate occurred when complex IV reached the saturation constraint. This was in good 
agreement with the maximum oxygen uptake rate observed in muscle fibers (Larsen et al. 2012). 
The model predicted a shift from a mode with full respiration to a mode where complex I was 
saturated and thus bypassed. The oxygen uptake rate where this occurred was in good agreement 
with observed oxygen uptake rates for muscle fibers restricted to NADH-producing substrates.  
Fermentation increased the ATP synthesis rate. The predicted exchange fluxes (Figure 10A) agreed 
with known physiology (Grassi et al. 1999), where metabolism was fully respiratory at low ATP 
synthesis rates, and fermentative at high rates. The maximum ATP synthesis rate (19.9 
mmol/gdw/h) occurred when GAPDH was saturated. This occurred at ATP synthesis rates 
around 3.6 times higher than the rate at which oxygen uptake was saturated. This is in good 
agreement with the relatively higher (3.2 times) maximum work rate (1130 W) compared with the 
maximum respiratory steady state rate (350 W) for exercise on cycle (Elmer et al. 2011). A trend 
towards higher predicted flux in reactions with high vmax was also noted (Figure 10B). 
22 
Prolonged fermentation at high rates is unsustainable, since lactate accumulates in the human body. 
However, at intermediate fermentation rates, lactate produced by one cell type may be used to fuel 
another (Brooks 2009). The metabolic interaction between multiple cell types can be studied using 
a multi tissue model (Bordbar et al. 2011; Shaw & Cheung 2018). Previous multi tissue models of 
human do not use enzyme-constraints, and have not been applied to study exercising humans. A 
model of the muscle system of the full body was reconstructed to study these dynamics. The model 
 
Figure 10. Predicted and experimental ﬂuxes for a single muscle ﬁber and a human exercising on a bike. A) 
Predicted exchange ﬂuxes at diﬀerent ATP synthesis rates in a single muscle fiber. There was good agreement 
between predicted and observed maximum oxygen consumption rate in isolated muscle ﬁbers on NADH substrates 
only (CI) and NADH and QH2 substrates combined (CI+II). The predicted oxygen consumption would be 
underestimated in the absence of a complex I constraint (dashed line). B) Acceptable agreement (Pearson correlation 
0.7) between maximum ﬂux and the highest predicted ﬂux amongst all ATP synthesis rates. Complex I (CI), complex 
IV (CIV) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were rate limiting. C) Predicted oxygen ﬂux and 
lactate concentration (lines) were in good agreement with experimental data (points). The predicted oxygen ﬂux 
without complex I bypass (gray line) shown for reference. D) There is a shift from fatty acid metabolism towards 
glycolysis at high work rates. 
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consisted of 3 genome-scale models that were joined together by an additional compartment. This 
allowed exchange of extracellular metabolites between the sub-models, thus resembling the blood 
stream. The sub-models were parameterized to represent muscle fibers with high mitochondrial 
content (type I fibers) and with intermediary mitochondrial content (type II fibers). The third sub-
model represented peripheral tissues and accounted for metabolic events that do not take place in 
the active muscle. Parameters were fitted to constrain the flux through complex I and complex IV, 
the reactions with active constraints in the muscle fiber model. A maintenance energy expenditure 
rate was also fitted based on the oxygen expenditure of the subject at rest. 
The multi-tissue model described the experimental fluxes from an exercise bike. The optimal fluxes 
were simulated for a subject cycling on a stationary bike at increasing work rates. ATP synthesis 
was constrained and an objective function was minimized. The objective function reflected a 
tradeoff between minimization of oxygen uptake and glycogen expenditure. There was good 
agreement (Figure 10C) between the predicted exchange fluxes and experimental data. The model 
described a super-linearity in the oxygen expenditure, reflecting complex I bypass. It also described 
the shift from fatty acid synthesis towards utilization of glycogen and the excretion of lactate by 
type II fibers and metabolism of lactate by type I fibers (Figure 10D). 
Interpretation of phenotypic predictions 
Mechanistic relations are inferred from the models. Extracting knowledge from data is an emerging 
challenge. Data is seldom stored in a form that is easily accessible for humans. Simulation results 
and experimental datasets are consistently increasing in information content, due to improvements 
in computational power and data generation from high throughput experiments. In the previous 
section I presented the models and some of the predicted phenotypes. In this section I analyze the 
models and the simulation results, to infer mechanistic relations behind the predicted phenotypes. 
Elasticity of growth with respect to the ATP synthesis rate 
Biosynthesis depends on input of free energy in the form of ATP. Fast growing cells must 
therefore synthesize ATP at higher rates than slow growing cells. There is thus a near linear 
relationship between ATP synthesis and specific growth rate for fast growing cells. For slow 
growing cells the energy expenditure for maintenance dominates the energy budget, and factors 
other than specific growth rate explain the ATP synthesis rate. In the infant, such factors include 
changes in body composition and increased physical activity with age (Wells & Davies 1998). There 
is currently no model available to predict all ATP demanding processes associated with growth. 
The ATP cost of growth (G) is thus estimated from the relation between ATP synthesis (T), 
maintenance (M) and growth (µ). 
𝑇𝑇 = 𝐺𝐺µ + 𝑀𝑀 
This expression can be rearranged to predict growth from ATP synthesis, an implicit assumption 
that explains much of the prediction power of GEMs (Durot et al. 2009). ATP synthesis and 
growth rates span orders of magnitude when comparing different organisms (Figure 11A). This 
may affect the simulations. 
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An elasticity analysis was performed on the linear model which underlies the growth predictions 
of GEMs (Figure 11B). The elasticity of growth to perturbations in total ATP synthesis and 
maintenance depends on the specific growth rate. At higher specific growth rates, the maintenance 
expenditure becomes asymptotically negligible, and growth becomes directly proportional to the 
ATP synthesis rate. At low specific growth rates, growth is hypersensitive to fluctuations in both 
maintenance energy and total ATP synthesis. In the context of GEMs this means that 
perturbations in fluxes supplying the maintenance reactions may have greater than proportional 
effects on growth.  
The direct proportionality between ATP synthesis rate and growth emphasizes that increased ATP 
synthesis rates may be of great value to a growing organism. It should however be noted that the 
linear relation between energy expenditure and growth does not necessarily imply that growth is 
constrained by the ATP synthesis rate. It may also reflect parsimonious resource utilization where 
the cells synthesize no more ATP than what is required, even though the potential capacity may 
have been higher. 
The hypersensitivity to perturbations in ATP synthesis and maintenance at low growth rates may 
be an underlying explanation for growth spurts, where the specific growth varies strongly from 
day to day (Dobbing & Sands 1973; Wales & Gibson 1994). It may also explain the prevalence of 
under and over weight in infants, as small variations in environmental factors may translate to large 
differences in outcome. This assumes that no compensatory mechanisms may act to dampen the 
effects. In living humans such compensatory mechanism are known to exist (Byrne et al. 2017). 
 
Figure 11. Growth rate dependent ATP synthesis rate and elasticity. A) Linear ﬁts to literature data on growth and 
ATP synthesis rates for yeast cells, mammalian cells and infants (Hoek et al. 1998; van Hoek et al. 1998; Butte 2005). 
The range of steady state ATP synthesis rates in the exercising muscle as reference. B) Growth rate dependent 
elasticity to perturbations in total energy intake and maintenance energy expenditure for the model T=Gµ+M with 
M=0.5 and G=150. For mammalian cell lines and yeast cells the model predicts negligible eﬀects of maintenance (M 
<< T), and that growth is proportional to energy expenditure (M/T ≈ 0). For infants (M ≈ T) growth is hyper sensitive 
to changes in both maintenance and energy intake. 
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NADH and overflow metabolism 
There are several different ways to synthesize ATP. Cells synthesize ATP through substrate level 
phosphorylation in glycolysis and the TCA cycle and through oxidative phosphorylation (Figure 
12A). Aside from ATP, glycolysis also generates pyruvate and NADH. The pyruvate may be 
further metabolized to CO2 through the TCA cycle or converted to a fermentation product, e.g. 
lactate or ethanol, and released from the cell. The fermentation products lactate and ethanol 
dispose of both the carbon from pyruvate and the electrons from NADH. The free energy stored 
in NADH and QH2 may also be converted to a proton gradient and then ATP by oxidative 
phosphorylation.  
Overflow metabolism is a phenomenon where cells ferment a carbon source even in the presence 
of oxygen. Overflow metabolism appears to be the preferred metabolic strategy under conditions 
where high ATP synthesis rates are required and substrate availability is not limiting (Molenaar et 
al. 2009). Thus, overflow metabolism is observed in fast growing yeast, in the vigorously exercising 
muscle and in many cancer cells. Respiration has a lower catalytic efficiency (ATP synthesis/g 
protein) than fermentation (Figure 12B). The models of yeast and human predict that fermentation 
is 2-3.5 times more catalytically efficient than respiration. It is particularly complex I and complex 
V that make respiration inefficient (Figure 12C). The modeling suggest that cells may bypass 
complex I to achieve a higher catalytic efficiency of respiration, at the expense of a lower substrate 
efficiency (ATP/substrate). This occurs by default in S. cerevisiae, as it lacks a proton pumping 
complex I (Dashko et al. 2014). Uncoupling of the respiration chain through complex V bypass 
results in a lower catalytic activity than respiration, despite the low catalytic activity of complex V. 
This may not be surprising since it is responsible for the bulk of the ATP synthesis from 
respiration.  
The synthesis of NADH is balanced under fully fermentative conditions. But in growing yeast cells 
the drain of pyruvate for biosynthesis and NADH production from other processes results in 
excess formation of NADH (van Dijken & Scheffers 1986). Because of the low efficiency of 
respiration this may become a burden to the cells. Excess NADH can be relieved through glycerol 
synthesis from glucose, which occurs under oxygen limited conditions. This disposes NADH more 
efficiently than respiration (NADH/g protein), but comes at a cost of ATP (Figure 12D). 
Uncoupling of respiration is 40% more efficient than glycerol synthesis and does not require an 
ATP investment. This suggests that yeast may use uncoupled respiration to manage excess NADH. 
Petite yeast cells lack mitochondria and thus cannot uncouple excess NADH. The specific growth 
rate of these yeasts is around 25% lower than that of normal yeast (De Deken 1966). 
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Figure 12. Trade-oﬀ between catalytic eﬃciency and substrate eﬃciency. A) Schematic representation of energy 
metabolism. B) Pareto front for maximizing the catalytic and substrate eﬃciency in muscle and yeast. C) Comparison 
of the speciﬁc activity of the enzyme complexes involved in oxidative phosphorylation in human, with the median 
values of intermediary metabolism as reference. D) Uncoupling is the most protein eﬃcient strategy to handle NADH-
imbalances. Abbreviations: complex I-V (CI-V), pyruvate (PYR), ubiquinol (QH2) and proton gradient (∆H+). 
The phenotypic effects of metabolite depletion 
Metabolite depletion affects ATP synthesis and growth. Cells may adapt to depletion of a 
metabolite by reallocating their proteome to utilize another. Due to differences in catalytic 
efficiency of the metabolic pathways, the rate of ATP synthesis and thus growth may differ 
between metabolites. Metabolites with high growth rates are often consumed first, and metabolite 
depletion is hence associated with decreased proliferation rates. Metabolic models with interior 
constraints may provide insight into these dynamics.   
The growth rate of yeast depends on the carbon source. The enzyme-constrained yeast model was 
used to predict the maximum growth rate on different substrates (Figure 13A). The predicted 
growth was higher on glycolytic substrates compared to non-fermentative due to the higher 
catalytic efficiency. In a follow up study using a GEM, these results were replicated for a large set 
of different metabolites (Sánchez et al. 2017). 
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The finite metabolite deposits in the human body explain differences in running-speed. The human 
body contains reserves of different metabolites, around 0.5 kg of glycogen in muscle tissues, 0.1 
kg of glycogen in the liver, and large reserves of fat. Due to the difference in maximum specific 
ATP synthesis rates on different substrates, the exercising human must economize these resources 
to achieve high sustained ATP synthesis rates. At high work rates, lactate accumulates, as it is 
produced at higher rates than it can be cleared. The maximum lactate concentration that can be 
tolerated becomes an additional constraint. For longer exercise durations, the sustainable specific 
consumption rates are lower, and the predicted maximum specific power output is thus also lower. 
Assuming that the metabolite pool is depleted at the end of the exercise, then the maximum steady 
state flux is given by the pool size divided by the duration. With these modeling assumptions a 
 
Figure 13. Phenotypic eﬀects of metabolite depletion in yeast and human. A) The enzyme-constrained model of 
yeast was used to predict the maximum speciﬁc growth rate on two glycolytic substrates (blue dots) and two non-
fermentative substrates (orange dots). B) The full body muscle model was used to predict the maximum work rate 
on diﬀerent substrates (gray lines). The maximum sustainable work rate and optimal metabolic strategy, respiration 
(orange dots) or respiro-fermentation (blue dots) was predicted for increasing exercise durations (numbers and gray 
subplot). There was good agreement between predicted speciﬁc power output and the average speed, which is a 
function of power at diﬀerent durations. C) High speciﬁc growth rates in the infant model were associated with high 
glucose utilization between the age 3-179 days. D) The ATP synthesis rates in the cancer model depend on the 
substrate availability. The results suggest modular contribution from the diﬀerent subsystems. 
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good agreement was found between world-record running-speeds and the maximum predicted 
power output for different exercise durations (Figure 13B). 
Infants shift metabolic strategy with age. In humans, it is possible to determine which carbon 
source is utilized from non-invasive respiratory measurements. The ratio of CO2 eliminated to O2 
consumed (RQ=vCO2/vO2) tells if glucose (RQ=1), fat (RQ=0.7) or a mixture is used 
(0.7<RQ<1). The predicted RQ was compared with the predicted specific growth rate in the infant 
model (Figure 13C) it showed an association between growth and high glucose utilization. This 
may reflect the higher energy synthesis capacity on glucose, but could also be an indirect effect of 
increased fat storage rates, and thus lower fat usage, at high growth rates. 
ATP synthesis rates correlate with cellular growth in cancer. ATP synthesis rates have been shown 
to correlate with growth in mammalian cells (Xie & Wang 1996). The ATP synthesis rates were 
characterized for the cancer cell lines under various nutrient conditions. A modular contribution 
from the different ATP synthesis pathways was found, consistent with enzyme capacity 
constraints. Cells cultivated in the presence of glucose had a higher ATP synthesis rate than cells 
cultured without (Figure 13D). Cells cultured under glutamine depleted conditions had yet lower 
levels. The contribution from various sources made ATP supply robust, and growth proceeded 
also in the absence of several growth enhancing metabolites. The sensitivity of growth was 
investigated for partial and complete inhibition of these pathways (Figure 14A) using acute 
sensitivity analysis. The predicted growth reduction was in agreement with the reduction that could 
be expected based on the pathways relative contribution to the total ATP synthesis flux. The 
predicted effects at full inhibition were in reasonable agreement with the predicted growth under 
nutritional conditions where the flux through these pathways was zero. Sensitivity analysis was also 
applied to investigate increased flux through the maintenance reaction. Under some conditions the 
growth response was greater than what would be anticipated from a linear analysis (Figure 14B).   
Compartmentalization and overflow of glutamate 
Many cancer cells excrete glutamate. The excretion rates correlate with growth rate and 
aggressiveness of the cancer (Stepulak et al. 2014). The precursor of glutamate, glutamine, is often 
consumed at high rates by cancer cells (Wise & Thompson 2010). Glutamate is the first 
intermediate in the metabolism of glutamine (Figure 15A) towards several important downstream 
products, e.g. α-ketoglutarate (AKG), aspartate (ASP), alanine (ALA) and pyruvate (PYR). 
Glutamate arises as a byproduct from nitrogen donation by glutamine in several biosynthetic 
processes, e.g. the synthesis of nucleotides. It is also a byproduct of deamination of branched chain 
amino acids (BCAA). Many cancer cells overexpress the first step in BCAA metabolism, the 
BCAT1 enzyme. The de novo synthesis of serine by phosphohydroxythreonine aminotransferase 
(PSAT) consumes glutamate and releases AKG.  
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Due to the physical structure of the cell, excreted glutamate must come from the cytosol. The 
interior fluxes surrounding cytosolic glutamate were investigated using the compartmentalized 
model of liver cancer cell metabolism (Figure 15B). The production of cytosolic glutamate were 
found to outweigh the consumption, so that excess glutamate must be transported to another 
compartment to ensure mass balance. Rather than transporting glutamate to the mitochondria to 
be further metabolized, the cells excreted it. 
It is not clear why the cells elect to excrete glutamate. The mitochondria clearly has capacity to 
metabolize glutamate, as it consumes glutamine, and thus glutamate, at high rates. It could be due 
to an unfavorable concentration gradient, however glutamate appears to be readily transported 
into the mitochondria as part of the malate-aspartate shuttle, which moves the charge of NADH 
in the cytosol to NADH in the mitochondria. The malate aspartate shuttle is located in the 
intermembrane space, and may potentially not be accessible for cytosolic glutamate. It may also be 
due to the glutamate transporter being an antiporter with aspartate (Figure 15C). If the cell solved 
the imbalance of glutamate by transporting it to the mitochondria, it may instead have to solve an 
imbalance in aspartate, since all compartments are mass balanced.  
I hypothesized that blocking glutamate export would affect fitness negatively. With the excretion 
option blocked, the cell would need to reduce the fluxes through BCAA metabolism or 
biosynthesis to uphold flux balance. An inhibitor of glutamate transport (sulfasalazine) was added 
to the medium. It reduced both glutamate production and the proliferation rate, and allowed the 
hypothesis to be validated (Figure 15D). 
 
Figure 14. Predicting the eﬀect of perturbations using interior constraints derived from estimated ﬂuxes. A) Acute 
sensitivity analysis was applied to the cancer model to predict growth eﬀects from reduced ﬂux through glycolysis, 
glutaminase and oxidative phosphorylation (solid lines). For glycolysis and oxidative phosphorylation the predictions 
are compared with the expected eﬀect (dashed line) based on the pathways’ contribution to ATP synthesis and the 
model T=150µ+0.5. The predictions at full inhibition are compared with the speciﬁc growth rate under glucose 
depleted (blue point) and glutamine depleted (orange point) conditions. B) The growth eﬀects are predicted for 
increased maintenance energy expenditure using ASA. Model predictions (solid lines) are compared to the expected 
eﬀects (dashed lines) calculated from the model T=150µ+0.5. 
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Figure 15. Eﬀects of the imbalance in the cytosolic glutamate ﬂux. A) Schematic representation of the ﬂuxes 
surrounding cytosolic and mitochondrial glutamate.  B) The sources and sinks of cytosolic glutamate are imbalanced 
under several diﬀerent conditions. Excess glutamate is transported to other compartments, primarily the 
extracellular compartment. C) The inﬂux of glutamate into the mitochondria must be balanced by an eﬄux of 
aspartate due to the glutamate-aspartate antiporter. D) Increasing concentrations of sulfasalazine (SSZ) inhibited 
glutamate export and reduced the speciﬁc growth rate of the cells. 
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Discussion 
In this thesis, metabolic models of human and yeast were developed. Models with boundary 
constraints were used to predict internal fluxes, and models with interior constraints were used to 
simulate the trade-off between different metabolic strategies. Preexisting methods were modified 
to improve model accuracy and better interpret the constraints on growth and ATP synthesis. I 
aimed to understand how biophysical constraints shape the fitness landscape of the cell, and how 
phenotypes emerge from optimization of protein allocation. For cancer cells, the development 
towards optima appears to be incomplete, several regulatory constraints from the cell of origin 
appear to remain. Some phenotypes of the cell lines may be remnants of social interactions from 
the in vivo condition. Various data types are integrated through modeling, thus biological models 
have potential to unify knowledge from different studies and domains. This may expose 
contradictory claims and highlight what remains unknown.  
Development of new metabolic models and simulations 
In this thesis, I developed mechanistic models of processes involved in growth and ATP synthesis. 
Much work has already been done in this area and preexisting methods and models were modified 
to improve their scope and quantitative accuracy. 
In this thesis, the first GEM of an infant was developed. The whole body of the infant was modeled 
as if it consisted of a single cell type with accesses to all biochemical reactions encoded by the 
human genome. In the reconstruction the HMR 2.0 model was used, but it was possible to port 
the simulations to the Recon3D model (Brunk et al. 2018), yielding similar results. Earlier studies 
of infants had shown that changes in body composition and energy expenditure were of 
importance (Wells & Davies 1998; Butte 2005). A modular biomass composition was thus 
introduced as a function of age, based on the experimentally determined body composition. By 
integrating age dependent data on organ sizes, the hypothesis that age dependent changes in 
maintenance energy could be fully explained by changes in body composition (Wang 2012), was 
corroborated. The simulations showed that energy was the growth-limiting factor for breastfed 
infants. This justified the assumptions of the preexisting models (Fjeld et al. 1989; Butte 2005; 
Jordan & Hall 2008), which relied on converting all nutritional input to their corresponding energy 
content (kcal), using the Atwater factors. 
There already exist several GEMs of cancer cells, as well as other mammalian cell types (Shlomi et 
al. 2011; Agren et al. 2012; Agren et al. 2014; Sheikh et al. 2005; Martínez et al. 2012). The existing 
metabolic models of cancer that make use of experimental data are however small-scale models. 
In this thesis, I developed the first GEM of a cancer cell line constrained with data from a dedicated 
experiment. Previous models (Zielinski et al. 2017) had used published flux data (Jain et al. 2012) 
to show a correlation between metabolite excretion, and excessive uptake of amino acids. 
However, by using the full genome-scale model together with experimentally determined fluxes I 
could show a mechanistic relation between glutamate, branched-chain amino acids and cellular 
compartmentalization. The use of a genome-scale model, in favor of a small-scale model, exposed 
a high degree of variability for many of the fluxes. In general, only fluxes in close proximity to the 
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biomass equation and the exchange fluxes could be estimated with any certainty. The uncertainty 
for the remaining reactions may to some degree be a consequence of metabolic loops and 
synonymous submodules without effects on the overall analysis (Kelk et al. 2012). But it should 
be noted that many fluxes may differ from their predicted values, which limits the set of claims 
that can be made with certainty. 
There are previous metabolic models with enzyme-constraints for both E.coli, yeast and human. 
Some of these models used parameters derived from literature in favor of randomly sampled 
parameters, which increases the accuracy of the predictions (Adadi et al. 2012). I developed the 
first fully parameterized enzyme-constrained model of intermediary metabolism in yeast. In this 
work I introduced the idea to use proteomics data to constrain the total pool of enzymes to the 
experimentally observed levels, the P-parameter. This parameter attempted to address the issue 
that the model only covers a part of the activities of the cell, and prevented the predicted enzyme 
concentrations from becoming unrealistically high. An enzyme saturation parameter was also 
introduced. This parameter attempted to capture the difference between the effective flux in the 
cell and the maximum flux of an enzyme under optimized conditions. In this thesis the parameter 
was set to 0.5 for all enzymes. Whilst this assumption may be correct on average, the accuracy of 
the enzyme concentration predictions was modest in most cases. New types of models are under 
development (Noor et al. 2016), which allow the saturation of each enzyme to be estimated. They 
predict the optimal enzyme concentrations and substrate concentrations of the cell simultaneously, 
by minimizing the enzyme cost. 
There are two previous models of ATP synthesis in muscle fibers using enzyme constraints 
(Vazquez et al. 2010; Vazquez & Oltvai 2011). The constraints of these models were however not 
on the level of individual enzymes, but were based on the assumed crowding capacity of different 
compartments. In this thesis, I reconstructed the first enzyme-constrained model of intermediary 
metabolism in muscle fibers with parameter values from literature. These parameters were 
integrated with proteomics data to estimate the effective vmax of each enzyme-constrained reaction. 
The reactions with active constraints were identified and constrained in a GEM. For this I 
developed the first multi tissue GEM of the human muscle system. It was used to study the lactate 
shuttle and the maximal fat oxidation capacity of cells. It was also used to study the phenomenon 
that the running speed in exercising humans decreases as a function of the length/duration of the 
race. Whilst this has been studied before using mathematical models of world record performance 
(Peronnet & Thibault 1989), a more detailed mechanistic description was achieved using the GEM. 
The differences in ATP yield from different carbon sources together with limited pool sizes 
allowed the optimal work output to be predicted for different exercise durations. 
Constraint-based modeling at low specific growth rates 
Survival may be even more fundamental than growth. The mechanisms for survival are normally 
modeled as growth-independent maintenance fluxes, e.g. a constant expenditure of ATP. At low 
specific growth rates, the maintenance reactions drive the fluxes. This makes the growth 
predictions sensitive to perturbations in energy metabolism and to nutrient intake. For most 
applications the predicted growth does not decrease more than proportionally to a reduction in 
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any flux, since FBA models are linear equation systems. But at low predicted growth rates the 
maintenance fluxes introduce an exception to this and also a small decrease in ATP synthesis 
markedly reduces the predicted growth rate. If the rate of ATP synthesis is insufficient to meet the 
maintenance requirement, the simulations become infeasible. This may be interpreted as death, 
since the organism is not able to meet the requirements for survival. In the living cell, maintenance 
fluxes are often more plastic than in the simulations, and cells have been shown to survive at ATP 
synthesis rates below the maintenance requirements found in growing cells (Vos et al. 2016). 
Infeasibility often occurred when perturbing the simulations of infant growth (Paper I). This was 
resolved by introducing a second optimization where ATP synthesis from the fatty acid stores was 
minimized to fulfill the maintenance requirement. 
Despite the methodological challenges at low growth rates, maximization of growth was still a 
viable objective function. This can conversely be viewed as parsimonious energy intake of the 
infant. In the absence of interior constraints on growth, the model would predict unrestricted 
growth for unrestricted milk intake. This is clearly not physiological, but was not a practical 
concern since infants did not consume milk in these quantitates (Butte et al. 2002). If the model 
were to be adapted to simulate child obesity, appropriate interior constraints on the synthesis of 
lean mass would have been required to ensure the accumulation of fat tissue. 
FBA simulations assume that growth is exponential. An implicit assumption of FBA is that cells 
grow exponentially with some rate µ (1/h), which depends on the flux of biomass (X) over the 
boundary. This assumption arises from the use of mass specific fluxes (mmol/gdw/h). 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= µ ⇒ 𝑑𝑑𝑡𝑡 = 𝑑𝑑0𝑒𝑒µ𝑡𝑡 
For some applications this assumption may not be suitable, e.g. for cells growing in monolayers, 
in tumors where only a fraction of the cells are actively growing (Murphy et al. 2016) or for yeast 
cells growing as stalks (Vulin et al. 2014). Assuming exponential growth for linearly growing cell 
cultures may result in marked underestimation of the specific growth rate and uptake fluxes in the 
growing portion. Whilst at the same time fluxes may be overestimated for the quiescent cells. At 
short time scales or low specific growth rates the linear and exponential models become nearly 
equivalent (by tailor expansion to the first order).   𝑑𝑑0𝑒𝑒𝑡𝑡µ ≈ 𝑑𝑑0(1 + 𝑑𝑑µ) 
The growth rate of an infant declines over time and a linear growth model may be more appropriate 
than an exponential. Due to the low specific growth rate and high time resolution (day-to-day 
resolution) used in this thesis, the differences between the two models is expected to be low.   
Modeling of mineral deficiencies 
A method to model the effects of mineral deficiencies in a cell was introduced. The method was 
conceptually similar to earlier sensitivity tests. It is common to constrain flux through sets of 
reactions, e.g. all reactions sharing a gene or all reactions sharing a metabolite (Agren et al. 2014; 
O’Brien et al. 2015). The concept was expanded to the set of reactions that share a certain mineral 
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cofactor. The approach has clear potential for generalization and the recent cross-referencing of 
human metabolic networks with protein structural databases and cheminformatics platforms 
(Brunk et al. 2018), opens up many possibilities to construct and simulate informative reaction 
sets. The simulated reduction in flux is intended to mimic a reduced concentration of active 
enzyme due to insufficient mineral concentrations. In principle it should be possible to obtain a 
rough estimate of the mineral demand of a cell directly from the abundance and stoichiometry of 
mineral binding enzymes. These enzyme abundances could either be derived from enzyme 
estimates by the models or more directly from proteomics. In the future, model driven estimates 
of mineral requirements may be able to replace the current empirical recommendations for daily 
intake of mineral and vitamins.  
Genome-scale metabolic modeling of a cell culture 
Cancer cells consume many different metabolites simultaneously. A challenge for modeling growth 
of mammalian cells is the broad range of metabolites that are simultaneously consumed and must 
be quantified. In the cancer study (Paper II) most amino acids were measured (20/22), as well as 
glucose, lactate and pyruvate. Still additional assumptions were required about non-quantified 
exchange fluxes, e.g. tryptophan, CO2 and vitamins. Fetal bovine serum (FBS) is an undefined 
component of the culture medium. It contains metabolites that were not quantified, but which 
may potentially have been consumed, e.g. fatty acids. Many metabolites are essential for growth 
and have direct control over the growth predictions. The existence of multiple substrates made it 
less clear how to conduct simulations with fixed growth and minimization of substrate uptake. 
Growth maximization was therefore the only objective function used in these simulations. 
Metabolites are often depleted over the course of the cultivation. Metabolites depletion made the 
analysis more complicated. The time points of the depletion events were generally unknown and 
must therefore be identified by extrapolation of the metabolite consumption curves. The depletion 
events were also expected to affect the exchange fluxes and they therefore had to be refitted for 
each event. Most data was thus used to fit new sets of exchange fluxes, rather than to improve the 
accuracy and estimate the error of the fits. Not accounting for the depletion events would however 
have had an even more adverse effect on the flux predictions, as was seen in a high throughput 
study (Paper III). In addition to the metabolite depletion events, an initial metabolic phase was 
identified, where amino acids were consumed at markedly higher rates than at later time points. 
More frequent sampling and quantification of the protein secretion rates may be required to 
examine this phenomenon further. 
The uncertainty of the exchange fluxes was not assessed. Due to limitations in the experimental 
setup it was not possible to properly assess the experimental uncertainty of the fitted exchange 
fluxes. Whilst potentially important, this is commonly neglected in simulations using GEMs 
(Sánchez et al. 2014). Experience from this study (Paper II) stresses the value of identifiability 
analysis and dedicated experimental design. But it should also be noted that even if the complete 
flux distribution were to be estimated with high confidence, this distribution would likely only be 
one of the possible states for the cell. 
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From the large number of possible reactions (>8000) in the models, only a small fraction (<500 
reactions) carried flux. This may have several explanations. Many reactions are involved in 
biosynthesis of complex biomolecules which are not represented with this level of detail in the 
biomass equation, e.g. lipids (Sanchez et al. 2018). There may be nutrient sources that the cells do 
not encounter in the experimental setup. Protein modifications and tRNA loading (Feizi et al. 
2013) involve reactions that are not included in the models. Metabolic modeling with optimality 
principles will not predict the occurrence of undesired spontaneous reactions, but in the living cell, 
non-enzymatic reactions and enzyme promiscuity may result in the buildup metabolites that must 
be cleared with dedicated detoxification pathways, e.g. reactive oxygen species and the 
oncometabolite 2-hydroxyglutarate (Xu et al. 2011; Piedrafita et al. 2015). However, the 
quantitative effects of these reactions are likely low. Different maintenance tasks, such as 
upholding osmotic balance may also be influential. Finally, proteins that take part in signaling 
processes are often enzymes (Hyduke & Palsson 2010) and these are not expected to carry flux in 
the simulations. More refined simulations are required to cover all the activities of the cell. 
It was challenging to extrapolate the predictions of models with boundary constraints. The absence 
of internal capacity constraints made it unclear which fluxes were constraining growth and which 
fluxes were accidental. The introduction of acute sensitivity analysis (ASA), allowed some degree 
of extrapolation. It prevented uncontrolled growth in the absence of boundary constraints, and it 
appeared that the fluxes in one condition could be generalized as capacity constraints in another, 
in particular for reactions relating to ATP synthesis. 
Metabolic trade-offs in ATP synthesis 
There are multiple lines of evidence that limited ATP synthesis rate is a prevalent constraint in 
biology. Limited ATP synthesis may arise from capacity constraints in the ATP-synthesizing 
enzymes or constrained uptake of carbon sources and thus limited downstream flux.  
The major trade-off in ATP synthesis is between fermentation and respiration. It is driven by the 
low catalytic efficiency of respiration. Using sensitivity analysis, enzyme-parameters with a big 
effect on the predictions were identified; in the case of yeast this was primarily ATP synthase 
(complex V). Yeast cells ferment at high growth rates and they therefore grow slower on non-
fermentative carbon sources where respiration is the only option. Reduced glucose uptake rates 
through deletion of the low-affinity/high-capacity glucose transporter HXK2 in yeast makes 
fermentation non-viable and reduces growth (Schuurmans et al. 2008). Likewise reduced growth 
was observed in an adaptive laboratory evolution (ALE) aimed at removing the fermentative 
phenotype in yeast (Dai et al. 2018). In the carbon limited chemostat, growth aligns with the 
dilution rate at steady state. The high cell density at low dilution rates reduces the extracellular 
glucose concentration to near undetectable levels (Postma et al. 1989). This affects glucose uptake 
rates, and in turn ATP synthesis, and is likely the mechanistic explanation for the reduced growth 
rate in the chemostat. A minor metabolic trade-off is the bypass of complex I. This strategy is 
more catalytically efficient than complete respiration. The flux through complex I is constrained 
in muscle fibers, and was experimentally detectible as a reduced ATP yield per oxygen consumed 
in exercising humans. 
36 
The role of NADH in energy metabolism depends on the ATP synthesis strategy. The free energy 
carrying metabolite NADH is the source of most ATP under respiratory conditions, but the low 
efficiency of respiration makes NADH a liability under conditions where ATP synthesis needs to 
be maximized. If it cannot be balanced by consumption in the synthesis of fermentation products 
enzymes must be invested into clearing excess NADH. Uncoupled respiration is a strategy for 
clearing NADH predicted by the modeling. In yeast the permeability transition pore allows 
uncoupling of respiration (Beutner et al. 2017). In in human several dedicated mitochondrial 
uncoupling proteins (UCP1-4) exist. Under high intensity exercise in a small muscle group it was 
predicted that uncoupling can mitigate the accumulation of lactate. The increasing difference 
between the pulmonary oxygen expenditure and the oxygen expenditure in the leg at high exercise 
intensities may indicate that such a process takes place in humans (Poole & Richardson 1997). 
Interpretation of the constraints on ATP synthesis and growth 
ATP synthesis may be constrained in liver cancer cell lines. The predicted growth rate of the 
HepG2 cancer cell line was constrained by the uptake rates of several essential amino acids as well 
as synthesis of ATP. The balance between uptake and biosynthesis is consistent with parsimonious 
substrate utilization and may not be constraining the cell. The excretion of lactate suggests that 
ATP synthesis from respiration was an active constraint. It however appears that partial 
fermentation was sufficient (lactate/glucose < 2) to supply the required ATP, similar to what is 
observed for yeast at intermediary growth rates (0.28 < µ < 0.42) in the chemostat. This suggests 
a glucose uptake rate constraint as in the chemostat, or that some other constraint on growth limits 
the demand for further ATP synthesis. In support of a constrained ATP synthesis by respiration, 
the predicted growth was lower in the absence of glucose. Glutamine supported ATP synthesis, 
and a reduction in growth was observed after glutamine was depleted. This growth reduction was 
however likely due to the biosynthetic role of glutamine, since reduced glucose uptake flux and 
reduced lactate production also was observed, indicating a decreased demand for ATP. Our 
simulations and experiments suggest that cells prefer to not uptake cytosolic glutamate into the 
mitochondria, even when this would seemingly be beneficial. This suggests that mitochondrial 
uptake is constrained in the living cell. 
The growth of infants was limited by the ATP synthesis rate in the simulations. The growth rate 
was sensitive to perturbations in energy metabolism. It is thought that the high energy expenditure 
and low growth rate in infants may reflect an evolutionary trade-off between rapid maturity and a 
large brain (Kuzawa et al. 2014). The prevalence of growth spurts suggests that there may be 
sufficient enzymatic capacity to sustain higher growth than what is observed (Wales & Gibson 
1994) and thus that the constrained ATP synthesis rate arises from limited nutrient uptake rates. 
The degree of hunger and intake of breastmilk may in turn be driven by evolutionary pressure 
towards parsimonious energy usage. Regulatory constraints on hunger from growth hormones may 
be the fundamental explanatory factor behind observed growth rates under normal conditions. 
Regulatory constraints on metabolism 
Enzyme concentrations are optimized by evolution. At long time scales evolutionary pressure 
optimizes the kinetic parameters of enzymes towards what is biophysically feasible under the given 
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biological conditions. On shorter evolutionary time scales, kinetic parameters may not be 
dramatically improved. Evolution instead acts on the regulation of the cell to provide the most 
optimal enzyme concentrations for the encountered conditions. Solving an optimization problem 
in the computer thus mimics regulation, and is a model of the biophysical constraints on regulation. 
ALE experiments (Yu et al. 2018) have revealed that regulation may be optimized to a specific 
condition, which reflects fine-tuning of the cell’s protein allocation to the selective constraints.  
Genetic deletions modify the fitness landscape. The dependence on regulation to achieve an 
optimal protein allocation may constrain the cell to less than optimal performance under many 
circumstances. There is a dual causality, where biophysics shapes the fitness landscape, and 
regulation places the cell therein. An interesting case study is the combination of genetic 
engineering with ALE (Yu et al. 2018). The fitness landscape was reshaped by genetic deletion 
events that could not be overcome by evolution in the short term. In the background of these 
deletions, fatty acid secretion became the new optima. By evolving the cells, the regulatory program 
was allowed to identify this option, and high fatty acid synthesis rates were achieved. The short 
term evolution towards optima in response to a genetic events has potential to make ALE an 
interesting experimental setup to study rewiring of the regulatory network in cancer. 
Cancer cells evolve on a short timescale. Healthy cells have specific tasks within an organism and 
their growth is carefully regulated. Genetic events, e.g. mutations, deletions and copy number 
alterations, may affect the cell's signaling system and allow them to avoid checkpoints in control 
of nutrient supply, growth and dissemination, to become cancer cells (Hanahan & Weinberg 2011). 
Actively growing cancer cells undergo evolution due to acquired genomic instability. This allows 
them to adapt to new environments. Yet on an evolutionary timescale, cancer cells have only a 
short time to evolve. This suggests that the cells may not reach optimality before they become fatal 
or are treated. Thus the phenotypes of cancer cells may best be understood as a transition between 
the cell type of origin and some more optimized state.  
There are many strategies that may increase growth. By comparing the phenotype of many cancer 
cell lines we may gain an understanding of evolutionary conserved strategies. Fermentation of 
glucose and glutamine addiction appear to be two such strategies. Excretion of glutamate may also 
constitute such a strategy. These may be achieved through various regulatory paths, e.g. HIF1-α 
or truncation of oxidative phosphorylation through succinate dehydrogenase (Yizhak et al. 2015). 
But there are also examples of increased ATP synthesis through increased respiration. It is debated 
whether the changes observed in cancer metabolism are driving (supply model) the cancer 
progression or if they are driven (demand model) by increased consumption rates (Ward & 
Thompson 2012). 
Metabolism does not only support biosynthesis. Cancer cells evolve to evade the immune system. 
It has been proposed that some of the metabolic activities of cancer cells take part in 
communication with the immune system (Adams et al. 2015). This may be an attractive explanation 
for metabolic phenotypes for which a biosynthetic explanation cannot be found. An example may 
be the release of ornithine seen in many cancer cells (Jain et al. 2012). The overconsumption of 
branched chain amino acids could not be explained by any biosynthetic requirement. This may 
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indicate a role in signaling or communication. It has been proposed that metabolism of branched 
chain metabolism affects fermentation signaling through HIF1-α, through metabolic interaction 
with α-ketoglutarate (Raffel et al. 2017). It was assumed that the cancer cell line secreted proteins, 
and secretome analysis shows high abundances of native proteins (Caruso et al. 2017), which may 
indicate incomplete optimization. But the secretome also shows high levels of metalloproteases, 
which may be used to modify the extracellular matrix. The secretion of these proteins drained 
resources without any apparent benefit for the cells under the laboratory conditions, but may be 
an adaptation to increase growth in vivo. 
Ethical and environmental risks and benefits 
The use of computer models in this thesis allowed experiments to be performed at high pace and 
at a low economic and environmental cost. The computer models largely relied on prior knowledge 
and parameter values from literature. There is a risk that errors may propagate from these sources 
to incorrect model predictions. Non-canonical components may not be represented in the model 
and this may thus bias predictions in favor of prior assumptions.  
Knowledge was generated about biological systems of high public interest, which has potential to 
improve both health and economy. With this comes the ethical risk that the results may be over- 
or misinterpreted. This could result in the use of inappropriate strategies in treatment of cancer, 
faulty nutritional management of infants, ineffective training regimes for sportsmen and wasted 
economic or environmental resources in the biotechnological industry. The risk of these scenarios 
was assessed to be minor since the results are on the level of basic research and the methods are 
relatively straight-forward to interpret. In this thesis I attempted to keep the titles of the 
publications short, to facilitate their impact (Letchford et al. 2015). However, a short title will in 
general contain less information than a longer title and may increase the risk for misinterpretation. 
The pharmaceutical industry is an external stakeholder in this project, since it benefits from an 
improved understanding of biology. A closer relationship with the pharmaceutical industry could 
have been advantageous for the project. The loose connection to industry may prevent the results 
from coming to practical use, either due to lack of interest, or challenges in their application. 
Involving the stakeholders closer in defining the objectives and requirements may have decreased 
the risk. However, the research and development in the pharmaceutical industry is currently 
struggling with an innovation crisis (Munos 2009), and too close of a connection may have 
threatened the scientific independence of this work. However, the predictions can further be 
validated by pre-clinical researchers and may then be translated into the clinic with the help of 
pharmaceutical companies. 
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Perspective, towards a standard model of biology 
The standard model of particle physics has emerged as a unifying theory of fundamental forces 
and elementary particles (Ellis 1986). The model came out of a drive to integrate all physics into a 
theory of everything, a set of self-consistent equations from which the behavior of all matter and 
energy could (in principle) be derived. The standard model is not a theory of everything, e.g. it 
does not describe the gravitational force. But the model has been instrumental to systemizing 
physics and many predictions made by the model have later been experimentally verified, including 
the existence of several elementary particles. 
Analogously a unified model of biology may be envisioned. Such a model should be able to account 
for all biological observations, and could become a scaffold onto which all the knowledge of the 
field may be attached. Ideally new data should be tested against the theory and inconsistencies in 
the model or the data would thereby be exposed. The requirement to pre-register trials has been 
successful in the pharmaceutical industry where it appears to have reduced publication bias 
(Kaplan & Irvin 2015). Attempting to model all of these experiments could help to accentuate 
where the blank spaces in our knowledge reside. The amount of data generated in biology will only 
increase and the storage of knowledge in the form of a models is compact and persistent. It also 
allows new work to be built on earlier without detailed understanding of its origin. 
There are several ongoing attempts at generating unifying models of biology, e.g. the whole cell 
model (Karr et al. 2012) and the protein sector models (Klumpp et al. 2013). And the whole field 
of systems biology may be seen to have an integrative agenda (Brigandt 2013). FBA simulations 
with a GEM is a simplification of the more general problem to identify the dynamics for all 
metabolite and enzyme concentrations of the cell (Müller et al. 2015). Enzyme-constrained models 
constitute a significant advancement toward integrating GEMs with kinetic modeling and the fields 
of structural biology and evolutionary biology (Paper VI). The integration of kinetic parameter 
values in metabolic models link advancements in deriving enzyme function from sequence directly 
to the phenotype level. GEMs are moving from predictions about growth rates for single cells 
towards simulations of organs, multicellular organisms and interactions between hosts and 
microbial communities (Thiele et al. 2018). Enzyme-constrained models have potential to provide 
these simulations with a solid foundation in biophysics, but more reliable kinetic parameter values 
are required to move ahead. There is a need for a standardized characterization of all enzymes, the 
kinetome.  
The human genome project cost 3 billion U.S. dollars and lasted for 15 years (Collins et al. 2003). 
It is a successful example of a “big science” project in biology. The next logical step is a 
“functional” genome project, which would systematically characterize the functional properties of 
the proteins expressed by the genes. The results of such a characterization would form the basis 
for a bottom-up whole body model, and pave the way for a standard model of biology. 
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Conclusion 
Growth is the primary objective of the cell. Growing cells require ATP and metabolites that is 
supplied by metabolism. Metabolic phenotypes, as observed in the fluxes over the boundary of the 
cell, originate from interior constraints. Mechanistic relations in the living cell can be inferred from 
quantitative simulations of metabolism using mathematical models. These constraints are provided 
directly by enzyme-constrained metabolic models. They may also be inferred from analysis of the 
fluxes in boundary-constrained models. In this thesis I aimed to advance our fundamental 
understanding of growing cells, with implications for human health. By applying different types of 
metabolic models I was able to: identify the growth limiting factor for breastfed infants (the energy 
content); estimate the catalytic advantage of fermentation over respiration (2-3.5 times more 
efficient); identify an intermediate metabolic mode between respiration and fermentation (complex 
I bypass); quantitatively predict the growth rate for yeast grown on different carbon sources; and 
explain the excretion of glutamate in cancer cells (compartmentalization). This thesis demonstrates 
the value of systematic integration of knowledge using mathematical models. 
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